Clinical Research Directory
Browse clinical research sites, groups, and studies.
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Sponsor: Pfizer
Summary
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab Parent Studies.
Official title: ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2023-10-03
Completion Date
2032-02-22
Last Updated
2026-03-20
Healthy Volunteers
No
Conditions
Interventions
Elranatamab
Elranatamab is a heterodimeric humanized full-length bispecific IgG2 kappa antibody that targets BCMA on MM cells and CD3 on T cells
Locations (29)
UCHealth Poudre Valley Hospital
Fort Collins, Colorado, United States
UCHealth Harmony
Fort Collins, Colorado, United States
UCHealth Greeley Hospital
Greeley, Colorado, United States
Longs Peak Hospital
Longmont, Colorado, United States
UCHealth Longs Peak Medical Center
Longmont, Colorado, United States
UCHealth - Medical Center of the Rockies
Loveland, Colorado, United States
Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
Coral Gables, Florida, United States
University of Miami Hospital and Clinics Deerfield Beach
Deerfield Beach, Florida, United States
Sylvester Comprehensive Cancer Center
Miami, Florida, United States
University of Miami Hospital and Clinics - Griffin Cancer Research Building
Miami, Florida, United States
University of Miami Hospital and Clinics
Miami, Florida, United States
University of Michigan
Ann Arbor, Michigan, United States
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)
Detroit, Michigan, United States
St. David's South Austin Medical Center
Austin, Texas, United States
Epworth Freemasons
Melbourne, Victoria, Australia
Epworth Hospital
Richmond, Victoria, Australia
Slade Pharmacy
Richmond, Victoria, Australia
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Peking University Third Hospital
Beijing, Beijing Municipality, China
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Shandong Provincial Hospital
Jinan, Shandong, China
The first Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Centre Hospitalier Lyon Sud
Pierre-Bénite, Rhône, France
Japanese Red Cross Medical Center
Shibuya-ku, Tokyo, Japan
University Hospital,Kyoto Prefectural University of Medicine
Kyoto, Japan
National Taiwan University Hospital
Taipei, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan